← Leaderboards
Mark S Cushman
Purdue University West Lafayette
$7,250,821
Attributed
$7,250,821
Total exposure
7
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $843.4K · FY2005–14$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$7,250,821 · 7
By mechanism
U01$3,428,212 · 2
R01$3,051,162 · 3
P01$768,039 · 1
N01$3,408 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Enzyme Inhibitors”
- Randall J Bateman · Washington University$62,893,538
- David Heimbrook · Leidos Biomedical Research, Inc.$43,975,020
- Vern L. Schramm · Yeshiva University$28,993,424
- Lynn Kirkpatrick · Ensysce Biosciences, Inc.$25,909,597
- Richard M Weinshilboum · Mayo Clinic Coll Of Medicine, Rochester$25,509,522
- Benjamin F Cravatt · Scripps Research Institute$25,494,660
Research focus
Enzyme InhibitorsDrug Design /Synthesis /ProductionDesignStructureInhibitor/AntagonistBaseEvaluationEnzyme StructureLigandsBiologicalX Ray CrystallographyFutureRelative (Related Person)Drug KineticsHydrogen BondingMonitorAnalogReactionMolecularComplexEnzyme Inhibitor DrugsTissue /Cell CultureKineticsModification
Grant awards (34)
Novel Topoisomerase I Inhibitors$217,192
U01 · FY2014 · CA · contact PI
Novel Topoisomerase I Inhibitors$210,445
U01 · FY2013 · CA · contact PI
Novel Topoisomerase I Inhibitors$223,849
U01 · FY2012 · CA · contact PI
Novel Topoisomerase I Inhibitors$324,817
U01 · FY2011 · CA · contact PI
Novel Topoisomerase I Inhibitors$392,246
U01 · FY2010 · CA · contact PI
Novel Indenoisoquinoline Topoisomerase I Inhibitors$244,098
U01 · FY2009 · CA · contact PI
Chemistry$176,290
P01 · FY2009 · CA · contact PI
Novel Indenoisoquinoline Topoisomerase I Inhibitors$236,716
U01 · FY2008 · CA · contact PI
Ligands for Probing the Active Site of Lumazine Synthase$227,770
R01 · FY2008 · GM · contact PI
Chemistry$171,160
P01 · FY2008 · CA · contact PI
Novel Indenoisoquinoline Topoisomerase I Inhibitors$234,644
U01 · FY2007 · CA · contact PI
Ligands for Probing the Active Site of Lumazine Synthase$227,947
R01 · FY2007 · GM · contact PI
Chemistry$169,736
P01 · FY2007 · CA · contact PI
Novel Indenoisoquinoline Topoisomerase I Inhibitors$234,957
U01 · FY2006 · CA · contact PI
Ligands for Probing the Active Site of Lumazine Synthase$234,926
R01 · FY2006 · GM · contact PI
Chemistry$125,477
P01 · FY2006 · CA · contact PI
Ligands for Probing the Active Site of Lumazine Synthase$250,341
R01 · FY2005 · GM
Novel Indenoisoquinoline Topoisomerase I Inhibitors$244,961
U01 · FY2005 · CA
Synthesis of New NNRTLs for the Treatment of AIDS$222,679
R01 · FY2005 · AI
Chemistry$125,376
P01 · FY2005 · CA
Synthesis of New NNRTLs for the Treatment of AIDS$222,789
R01 · FY2004 · AI
Novel Indenoisoquinoline Topoisomerase I Inhibitors$221,767
U01 · FY2004 · CA
Novel Indenoisoquinoline Topoisomerase I Inhibitors$223,611
U01 · FY2003 · CA
Synthesis of New NNRTLs for the Treatment of AIDS$211,395
R01 · FY2003 · AI
LIGANDS FOR PROBING THE ACTIVE SITE OF LUMAZINE SYNTHASE$195,883
R01 · FY2003 · GM
Novel Indenoisoquinoline Topoisomerase I Inhibitors$205,508
U01 · FY2002 · CA
LIGANDS FOR PROBING THE ACTIVE SITE OF LUMAZINE SYNTHASE$196,199
R01 · FY2002 · GM
Novel Indenoisoquinoline Topoisomerase I Inhibitors$213,401
U01 · FY2001 · CA
LIGANDS FOR PROBING THE ACTIVE SITE OF LUMAZINE SYNTHASE$196,491
R01 · FY2001 · GM
SYNTHESIS OF NEW NNRTIS FOR THE TREATMENT OF AIDS$173,264
R01 · FY2001 · AI
SYNTHESIS OF NEW ANTIHIV AGENTS RELATED TO COSALANE$307,656
R01 · FY2000 · AI
LIGANDS FOR PROBING THE ACTIVE SITE OF LUMAZINE SYNTHASE$215,500
R01 · FY2000 · GM
SYNTHESIS OF NEW NNRTIS FOR THE TREATMENT OF AIDS$168,322
R01 · FY2000 · AI
SYNTHESIS OF CONGENERS &PRODRUGS$3,408
N01 · FY2000 · CM